SP 500 Climbs on Tech Strength Energy Staples Drag Perpetua Resources Secures 29 Billion US Loan for Idaho GoldAntimony Project Amid Critical Minerals Push Professional Title Morgan Stanley Cuts Home Depot Price Target by 20 Amid Housing Headwinds Wholesale Inflation Surges 6 Annually in April Marking Fastest Pace Since 2022 Chinese Investors Flock to Dividend Stocks Amid Limited Alternatives Market Trends Stocks Rise Treasury Yields Dip as Market Watches USIran Negotiations MDB Q1 2026 Earnings EPS Beats Estimates by 127 Stock Slips 35 Essential Utilities Inc WTRG Q1 2026 Earnings EPS Miss Overshadows Mixed Utility Demand SMMT Q1 2026 Earnings EPS Misses Estimates as Development Costs Mount C3ai AI Q1 2026 Earnings EPS Misses Estimates as Stock Edges Lower Neuraxis Inc NRXS Q1 2026 Earnings Narrower Loss Beats Estimates but Stock Slips on PreRevenue Concerns American Healthcare REIT Inc AHR Q1 2026 Earnings Strong EPS Beat Amidst Operational Improvements TSS Inc TSSI Slips 34 as Broader Pressure Tests Key Support at 1191 Brookfield Infrastructure Partners BIP Holds Near Support Amid Modest Decline Oracle Stock Soars 646 on Positive Momentum Approaching Key Resistance at 21345 Vericel Corporation VCEL Edges Higher as Stock Consolidates Above Key Support Fifth Era Acquisition Corp I FERA Holds Steady at 1038 Amid Neutral Trading More Couples Opt for Separate Bank Accounts Financial Risks and Considerations SB Q4 2025 Earnings Slight EPS Miss Amid Dry Bulk Market Volatility Energy Vault NRGV Stock Climbs 298 as Renewable Energy Storage Momentum Builds FFBC Q1 2026 Earnings EPS Surpasses Estimates by 8 Strengthening Investor Confidence Westrock Coffee Q1 2026 Earnings EPS Misses Estimates as Losses Widen Stock Slips AEBI Q1 2026 Earnings EPS Misses Estimates Yet Stock Edges Higher CNF Q4 2023 Earnings Massive EPS Surprise Driven by Exceptional Profitability GPCR Q1 2026 Earnings NarrowerThanExpected Loss Fuels Positive Investor Sentiment PLTK Q1 2026 Earnings EPS Misses Estimates by 5181 Amid Challenging Quarter RNTX Q1 2026 Earnings Narrowed Loss Beats Estimates as Rein Therapeutics Advances Pipeline